Christoph Westphal (L) and David Donabedian (Longwood Fund)
August 1, 2023 11:11 AM EDT
Financing
Startups

Long­wood launch­es start­up Solu with drug can­di­dates from GSK and $31M to start

Kyle LaHucik

Senior Reporter

Long­wood Fund’s Christoph West­phal, the co-found­ing in­vestor be­hind the likes of Al­ny­lam, TScan and Tome Bio­sciences, is out with an­oth­er new biotech whose pipeline …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times